| Fund ID | 805-1222373515 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | No |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | Yes |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 100% |
| Fund | Type | Gross assets |
|---|---|---|
| Marlin Fund, Limited Partnership | Hedge | $333.7M |
| Marlin Fund II, Limited Partnership | Hedge | $282.1M |
| Marlin Master Fund Offshore II LP | Hedge | $35.7M |
Sciens Group Alternative Strategies Pcc Limited-Blue Omega Cell reports $9.3 million in gross assets, among the top 78% of private funds by size.
The stated minimum investment is $250,000.
Sciens Group Alternative Strategies Pcc Limited-Blue Omega Cell is managed by Masters Capital Management, L.L.C.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.